The role of technology in diabetes therapy.
This decade will bring major changes to the therapy of diabetes. New drugs are likely to include monomeric insulins, fatty-acid-oxidation inhibitors, insulin-secretion inducers, and nutrition modifiers. Likely new devices include improved insulin pens, less invasive methods of insulin administration, and noninvasive blood glucose monitoring. The use of computers will integrate this care, and artificial intelligence will provide new approaches to all of health care. An integrated system for using these new technologies, such as staged diabetes management, will ensure an orderly, cost-effective transition in therapy by the entire health-care community.
Ginsberg
B H
BH
Medical Department, Becton Dickinson and Company, Franklin Lakes, New Jersey 07417-1883.
D001786:Blood Glucose / Q000032:analysis*; D003201:Computers; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007332:Insulin Infusion Systems; D008962:Models, Theoretical; D008991:Monitoring, Physiologic / Q000295:instrumentation*
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin